- Patients
- Clinical Research
- Find a clinical trial
- CA245-0001
Lung
CA245-0001
Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + nivolumab FDC) in combination with Carboplatin plus Etoposide vs Atezolizumab in combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer
Trial overview
Medical Oncology
Non-small cell lung cancer (NSCLC)
Lung & bronchus
III
Registration number: NCT06646276
Campbelltown (Oncology)
38 Camden Road, Campbelltown, NSW, 2560, Australia

Clinical trials enquiries
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.